Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2009/053626external-prioritypatent/WO2010023594A1/en
Application filed by PfizerfiledCriticalPfizer
Publication of CU20110041A7publicationCriticalpatent/CU20110041A7/en
Publication of CU24003B1publicationCriticalpatent/CU24003B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
En el presente documento se describen compuestos de fórmula (I) y usos de los mismos para el tratamiento de enfermedades, afecciones y/o trastornos mediados por inhibidores del transportador de glucosa dependiente de sodio (en particular, inhibidores de SGLT2).Compounds of formula (I) and uses thereof for the treatment of diseases, conditions and / or disorders mediated by sodium-dependent glucose transporter inhibitors (in particular, SGLT2 inhibitors) are described herein.
Heterocycle substituted phenylpiperidine derivative compounds; preparation procedure; pharmaceutical composition comprising it; and use in the treatment of cardiovascular, thromboembolic and tumor disorders; in vitro uses.
3'-n-desmethyl-4 '' - o- (2-diethylaminoetanoyl) -6-o-methyl-9a-aza-9a-homoerythromycin a, its salts and crystalline forms 1, 2 and 3; Preparation process; use to treat inflammatory diseases; pharmaceutical composition; and composition which also comprises another active compound.